BRIEF published on 08/29/2024 at 09:06, 2 months 23 days ago NuWays AG Recommends Holding Singulus Technologies AG Stock NuWays AG Financing Agreement SINGULUS TECHNOLOGIES Hold Rating Q2 Report
PRESS RELEASE published on 08/29/2024 at 09:01, 2 months 23 days ago Original-Research: Singulus Technologies AG (von NuWays AG): HOLD Singulus Technologies AG releases final Q2 numbers and successfully completes financing reorganization with CNBM. The company saw a decrease in Q2 sales but a higher gross profit margin in Semiconductor segment Singulus Technologies AG Financing Reorganization Q2 Numbers CNBM Semiconductor Segment
BRIEF published on 08/28/2024 at 08:05, 2 months 24 days ago SINGULUS TECHNOLOGIES Reports Preliminary Financial Figures for H1 2024 Gross Margin Joint Venture Order Intake Financial Figures Semiconductor Sector
PRESS RELEASE published on 08/28/2024 at 08:00, 2 months 24 days ago SINGULUS TECHNOLOGIES reports preliminary Key Financial Figures for the First Half of 2024 SINGULUS TECHNOLOGIES reports positive growth in key financial figures for the first half of 2024, including increased order intake and strong gross margin Gross Margin Order Intake Financial Figures SINGULUS TECHNOLOGIES Semiconductor
BRIEF published on 08/20/2024 at 20:41, 3 months ago SINGULUS TECHNOLOGIES AG Completes Financing Reorganization Half-year Report Financing SINGULUS TECHNOLOGIES Financial Reorganization Triumph Science And Technology
PRESS RELEASE published on 08/20/2024 at 20:36, 3 months ago EQS-Adhoc: SINGULUS TECHNOLOGIES AG: Reorganization of Financing completed - Publication of half-year report on August 28, 2024 SINGULUS TECHNOLOGIES AG completes financing reorganization and announces half-year report publication on August 28, 2024 Half-year Report 2024 Singulus Technologies AG Financing Reorganization August 28
BRIEF published on 08/13/2024 at 18:26, 3 months 7 days ago SINGULUS TECHNOLOGIES Delays Half-Year Report Amid Financing Talks Half-year Report Financial Obligations SINGULUS TECHNOLOGIES Financing Restructuring Triumph Science And Technology
PRESS RELEASE published on 08/13/2024 at 18:21, 3 months 7 days ago EQS-Adhoc: SINGULUS TECHNOLOGIES AG: Reorganization of financing - Publication of half-year report delayed SINGULUS TECHNOLOGIES AG negotiates financing reorganization with Triumph Science and Technology Group Co. Ltd., delaying the publication of the half-year report Half-year Report Singulus Technologies AG Triumph Science And Technology Financing Reorganization Delayed
BRIEF published on 07/25/2024 at 14:25, 3 months 26 days ago SINGULUS TECHNOLOGIES Holds Successful Annual General Meeting Sustainability Shareholder Approval AGM 2024 SINGULUS TECHNOLOGIES Thin-film Coating
PRESS RELEASE published on 07/25/2024 at 14:20, 3 months 26 days ago SINGULUS TECHNOLOGIES - Successful Annual General Meeting on July 25, 2024 SINGULUS TECHNOLOGIES AG reports successful Annual General Meeting with 31.63% attendance approving all agenda items. Positive outlook for 2024 with focus on sustainability and innovative products Annual General Meeting Sustainability 2024 Outlook Innovative Products Singulus Technologies AG
Published on 11/21/2024 at 13:30, 17 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 17 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 47 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 47 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 47 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 11 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 32 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 49 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 27 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 2 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 2 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
